A. Marco Alings - Concepedia

Concepedia

Author

A. Marco Alings

Amphia Ziekenhuis

Also Known As

A M W Alings, A M W Marco Alings, A Marco W Alings, A. M. Alings, A. M. W. Alings, A. Marco Alings, A. Marco W. Alings, Antonio Alings

21

Publications

1.9K

Citations

11

H-Index

17

Concepts

All Affiliations

Amphia Ziekenhuis University Medical Center Groningen University of Groningen Deventer Ziekenhuis Amsterdam UMC Location University of Amsterdam

AM

About

A. Marco Alings is an author at Amphia Ziekenhuis specializing in public health, medicine, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Public Health	4	4	482
2	Medicine	3	3	466
3	Nursing	1	1	16
4	Health Policy	1	1	16
5	Pharmacology	1	1	233

A. Marco Alings

×

11

Publications

1.9K

Citations

11

H-Index

	Year	Citations
Lenient versus Strict Rate Control in Patients with Atrial Fibrillation Isabelle C. Van Gelder, Hessel F. Groenveld, Harry J.G.M. Crijns, New England Journal of Medicine	2010	1K
Dronedarone for the control of ventricular rate in permanent atrial fibrillation: The Efficacy and safety of dRonedArone for The cOntrol of ventricular rate during atrial fibrillation (ERATO) study Jean‐Marc Davy, Martin Herold, Christer Höglund, American Heart Journal Electrophysiological EvaluationDevice TherapyCardiovascular DiseasePharmacologyCardiovascular Pharmacology	2008	233
Familial Evaluation in Catecholaminergic Polymorphic Ventricular Tachycardia Christian van der Werf, Ineke Nederend, Nynke Hofman, Circulation Arrhythmia and Electrophysiology	2012	168
The Effect of Rate Control on Quality of Life in Patients With Permanent Atrial Fibrillation Hessel F. Groenveld, Harry J.G.M. Crijns, Maarten P. van den Berg, Journal of the American College of Cardiology Quality Of LifeCardiovascular DiseasePermanent Atrial FibrillationRate ControlAtrial Fibrillation	2011	153
Effect of a nurse-coordinated prevention programme on cardiovascular risk after an acute coronary syndrome: main results of the RESPONSE randomised trial Clemens von Birgelen, A. Marco Alings, Anho Liem, Heart	2013	125
RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II Isabelle C. Van Gelder, Dirk J. van Veldhuisen, Harry J.G.M. Crijns, American Heart Journal Heart FailureCardiovascular DiseaseRate Control EfficacyCardiovascular PharmacologyCardiac Care	2006	80
LDL-C goal attainment with the addition of ezetimibe to on-going simvastatin treatment in coronary heart disease patients with hypercholesterolemia C. Brohet, Shmuel Banai, A. Marco Alings, Current Medical Research and Opinion	2005	44
Symptom severity is associated with cardiovascular outcome in patients with permanent atrial fibrillation in the RACE II study Rob A. Vermond, H. J. G. M. Crijns, J. G. P. Tijssen, EP Europace	2014	39
Performance of idarucizumab as antidote of dabigatran in daily clinical practice Sake J. van der Wall, Nienke van Rein, Bart J. F. van den Bemt, EP Europace	2018	38
Efficacy and Safety of Low-Dose Digoxin in Patients with Heart Failure. Rationale and Design of the DECISION Trial Dirk J. van Veldhuisen, Michiel Rienstra, Arend Mosterd, European Journal of Heart Failure	2024	17

Page 1